Pharmacovigilance Automation for Life Sciences
Intelligent Solution for Streamlined Drug Safety Monitoring
End-to-end vigilance and safety signal management across the drug lifecycle
At Mushroom Solutions, we deliver next-generation Pharmacovigilance (PV) Automation Solutions that help Life Sciences organizations enhance patient safety, ensure global regulatory compliance, and accelerate safety reporting across the entire drug lifecycle.
Our AI-powered PV platform integrates seamlessly with existing systems to monitor, assess, and manage adverse events (AEs) with unmatched efficiency, accuracy, and transparency.
Our Pharmacovigilance Solutions
Mushroom Solutions unites Artificial Intelligence (AI), Machine Learning (ML), and intelligent automation with regulatory expertise to streamline every stage of the drug safety process — from case intake to global submissions.
- Capture and manage ADR, ICSR, and SUSAR cases with automated validation for data accuracy and completeness.
- Streamline data intake from clinical trials, post-market surveillance, literature, and partner systems.
- Auto-generate CIOMS-compliant narratives from structured and unstructured data sources.
- Maintain consistency, accuracy, and audit readiness across submissions.
- Auto-generate E2B (R3) XML safety reports for FDA, EMA, and global health authorities.
- Enable seamless gateway validation, integration, and schema control.
- Regulatory Readiness Checks: Schema validation, MedDRA version control, WHO-DD mapping, and completeness reviews.
- Quality Controls: Duplicate detection, causality verification, and comprehensive audit trails for transparency and compliance.
- Automatically search PubMed, journals, and regulatory databases for disease, product, or keyword.
- Link published evidence directly to active safety cases for traceable documentation.
Extract AE information from emails, PDFs, EHRs, and call logs using DocuGenX, our proprietary AI document intelligence engine.
- Detect emerging safety patterns through AI/ML-driven analytics.
- Empower proactive risk mitigation and timely safety signal management.
Key Benefits
Mushroom Solutions focuses on "next-generation" automation that fits into existing infrastructures without disrupting current workflows.
- Plug-and-Play Compatibility: Their AI-powered PV platform is designed to integrate directly with existing pharmaceutical systems, including clinical trial databases and partner systems.
- Diverse Data Intake: The solution extracts Adverse Event (AE) information from a variety of unstructured and structured sources such as emails, PDFs, Electronic Health Records (EHRs), and call logs.
- Interoperable Gateway Submissions: It automatically generates E2B (R3) XML safety reports, enabling seamless gateway validation and integration with global health authority systems like the FDA and EMA.
The platform is built specifically to meet the rigorous regulatory requirements of the life sciences industry.
- Regulatory Readiness: It ensures all reporting is fully aligned with ICH E2B(R3), FDA, and EMA standards.
- Automated Validation: The system performs "Regulatory Readiness Checks," which include MedDRA version control, WHO-DD mapping, and schema validation to ensure data is submission-ready.
- Consistent Narratives: Using Generative AI and NLP, the platform auto-generates CIOMS-compliant narratives. This maintains consistency and audit readiness across all global submissions, reducing the risk of human error or regulatory non-compliance.
While "Adverse Events" (AEs) are inherent to drug use, Mushroom Solutions focuses on reducing the risks associated with them through proactive detection and faster management.
- Early Signal Detection: By using AI/ML-driven analytics, the platform can detect emerging safety patterns and signals early in the drug lifecycle. This allows companies to implement "proactive risk mitigation" strategies before a localized issue becomes a global safety crisis.
- Improved Accuracy & Data Quality: High-quality data extraction and duplicate detection prevent the "noise" of bad data from obscuring real safety signals.
- Accelerated Reporting: By reducing manual effort by 40–60%, the platform ensures that serious adverse events (like SUSARs) are reported to authorities much faster, allowing for quicker regulatory intervention and enhanced patient safety.
Core Value Highlights
Our Pharmacovigilance platform delivers measurable impact across safety, speed, and compliance:
Efficiency
Reduce manual effort by 40–60% with intelligent automation.
Speed
Accelerate submissions through real-time case linkage and validation.
Accuracy
Ensure consistent, error-free, and validated safety data.
Compliance
Stay fully aligned with ICH E2B(R3), FDA, and EMA standards.
Insight
Detect risks early and gain data-driven visibility into global safety trends.
Case Study: Narrative Automation for a Global CRO
Challenge :A global Clinical Research Organization (CRO) faced frequent delays and inconsistencies in CIOMS narrative generation due to manual, error-prone workflows — leading to high compliance risk and operational inefficiency.
Solution :Using Mushroom Solutions’ DocuGenX platform, the CRO deployed an AI-powered narrative automation solution combining Generative AI, NLP, and ML to automatically create, validate, and submit narratives aligned with ICH E2B(R3) standards.
✅ 60% faster submissions
✅ >99% narrative accuracy
✅ Global regulatory compliance (FDA & EMA)
✅ Reduced manual workload and improved data utilization
The CRO transformed its manual, resource-intensive reporting process into a digital, compliant, and intelligent Pharmacovigilance workflow, achieving faster submissions, improved accuracy, and higher operational efficiency.
Ready to modernize your Pharmacovigilance operations?
Connect with Mushroom Solutions to explore how our AI-powered PV automation can help you streamline safety case management, ensure compliance, and improve patient outcomes.